The Role of Growth Hormone Therapy in Managing Pediatric Hereditary Disorders

Authors

  • Kurbanova Nozima Sobirjanovna Assistant, Department of Endocrinology, Samarkand State Medical University

Keywords:

Growth hormone, panhypopituitarism, GH-releasing hormone receptor, hereditary genetic causes

Abstract

Growth hormone (GH) deficiency is the most common pituitary hormone deficiency in children and can occur in isolation or in combination with other pituitary hormone deficiencies. In typical cases, growth hormone deficiency in children is characterized by an abnormally low growth rate and short stature while maintaining normal body proportions. Diagnostics include measuring pituitary hormone levels and CT or MRI to detect structural abnormalities of the pituitary gland or brain tumors. Treatment usually includes hormone replacement therapy and removal of the tumor if it is causing the disorder.

References

Meerson F.Z. On the "price" of adaptation. Patol. physiology and experimental therapy. 1986; 3: 9-19.

Charmandari E., Tsigos C., Chrousos G. Endocrinology of the stress response. Annu. Rev. Physiol. 2005; 67: 259-284.

Horizons P.D. Homeostasis. M .: Medicine. 1981.576 p.

Daniels D., Fluharty S.J. Neuroendocrinology of Body Fluid Homeostasis. Hormones, Brain and Behavior. Second Edition. D.W. Pfaff, A.P. Arnold, S.E. Fahrbach (eds.). USA: Academic Press. 2009. P. 259-289.

Starkova N.T. Clinical Endocrinology: A Manual. SPb .: Peter. 2002.576 p.

Larzelere M.M., Jones G.N. Stress and health. Primary Care: Clinics in Office Practice. 2008; 35 (4): 839-856.

Garkavi L.Kh., Kvakina E.B., Ukolova M.A. Adaptive reactions and body resistance. Ed. 3rd, add. Rostov-on-Don: Publishing house of Rostov University. 1990.223 s.

Selye H. Stress without distress. Philadelphia, USA: Lippincott. 1974.171 p.

Gorobets L.N. Neuroendocrine dysfunctions and neuroleptic therapy. M .: Medpraktika-M. 2007.312 s.

Sobirdjanovna K. N. et al. Pros and Cons of Using a Combination of Glow-Lowing Drugs //Particular Dpp-4 Inhibitors and Metformin in Patients with Type. – Т. 2. – С. 50-53.

Sabirdjanovna K. N. et al. Development of Sarcoidosis after Successful Treatment of Itsenko–Cushing‘s Disease //JSML. – 2024. – Т. 2. – №. 5. – С. 91-98.

Sabirdjanovna K. N. et al. Diagnostic Aspects and Comparative Diagnostics of Thyroid Disease //JSML. – 2024. – Т. 2. – №. 5. – С. 99-106.

Sabirjanovna K. N. et al. Negative Impact of Covid-19 on the Endocrine System //American Journal of Pediatric Medicine and Health Sciences (2993-2149). – 2023. – Т. 1. – №. 8. – С. 148-153.

Sobirdjanovna K. N. et al. Assessment of the Level of Knowledge of Residents of Samarkand Region about Osteoporosis //JSML. – 2024. – Т. 2. – №. 4. – С. 45-49.

Sobirjonovna K. N. Factors determining the clinical significance of depiptidyl peptidase 4 inhibitors in the treatment of patients with type 2 diabetes mellitus //World Bulletin of Public Health. – 2022. – Т. 8. – С. 67-72.

Armario A., Marti O., Vallfes A., Dal-Zotto S., Ons S. Long-term effects of a single exposure to immobilization on the hypothalamic- pituitary-adrenal axis: neurobiologic mechanisms. Ann. N.Y. Acad. Sci. 2004; 1018: 162-172.

Downloads

Published

2025-04-21

How to Cite

Sobirjanovna, K. N. (2025). The Role of Growth Hormone Therapy in Managing Pediatric Hereditary Disorders. International Journal of Integrative and Modern Medicine, 3(4), 122–124. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/1732